Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|March 7, 2018
Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in BrazilMaurílio de Souza Cazarim, Leonardo Régis Leira Pereira
Sao Paulo Medical Journal = Revista Paulista De Medicina|August 25, 2016
Perspectives for treating Alzheimer's disease: a review on promising pharmacological substancesMaurílio de Souza Cazarim, Julio Cesar Moriguti, Abayomi Tolulope Ogunjimi, et al.
Plos One|June 16, 2016
Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after DischargeMaurílio de Souza Cazarim, Osvaldo de Freitas, Thais Rodrigues Penaforte, et al.
Journal of Nursing Measurement|March 22, 2024
Evaluation of Immunobiological Cold Chain CostsHeuler Souza Andrade, Maurílio de Souza Cazarim, Valéria Conceição de Oliveira, et al.
Current Diabetes Reviews|September 15, 2023
Potential use of Acrocomia aculeata Pulp Oil in the Modulation of Chronic Non-communicable Diseases, Especially in Diabetes: A Systematic ReviewMaurílio de Souza Cazarim, Davi Trombini Aleixo, Estael Luzia Coelho da Cruz-Cazarim, et al.
Diabetes & Metabolic Syndrome|December 24, 2017
Patients lacking glycemic control place more burdens on health services with the use of medicationsAna Márcia Tomé Camargos, Ana Carolina Oliveira Gonçalves, Maurílio de Souza Cazarim, et al.
Cadernos De Saude Publica|February 6, 2020
Cost-effectiveness analysis is a mandatory strategy for health systems: evidence from a study involving therapies for hepatitis CJoão Paulo Vilela Rodrigues, Maurílio de Souza Cazarim, Silvana Gama Florencio Chachá, et al.
BMJ Open Diabetes Research & Care|August 16, 2019
Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitusAna Carolina Oliveira Gonçalves, Maurílio de Souza Cazarim, Cristina Sanches, et al.
Diabetes & Metabolic Syndrome|July 14, 2017
Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitusMaurílio de Souza Cazarim, Estael Luzia Coelho da Cruz-Cazarim, André de Oliveira Baldoni, et al.
Pharmaceutics|September 28, 2021
A New Approach to Atopic Dermatitis Control with Low-Concentration Propolis-Loaded Cold CreamBianca Aparecida Martin, Camila Nunes Lemos, Luciana Facco Dalmolin, et al.
Pageof 2